Pharmaceutical combination of PPAR agonist and sterol absorption inhibitor and application thereof

Pharmaceutical combination of PPAR agonist and sterol absorption inhibitor and application thereof

The present invention relates to pharmaceutical combinations of peroxisome proliferator-activated receptor (PPAR) agonists and sterol absorption inhibitors, and the use of these combinations for the treatment and/or prevention of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatoh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RAI SANTOSH KUMAR, ALI, SAJID, BAPURAM SRINIVASAN REDDY, KUMAR ANIL, PATIL, RAKESH, ISWAR, VASISHT, BHAVIA
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to pharmaceutical combinations of peroxisome proliferator-activated receptor (PPAR) agonists and sterol absorption inhibitors, and the use of these combinations for the treatment and/or prevention of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH) and other related conditions. 本发明涉及过氧化物酶体增殖物激活受体(PPAR)激动剂与甾醇吸收抑制剂的药物组合，以及这些组合用于治疗和/或预防非酒精性脂肪肝病(NAFLD)和/或非酒精性脂肪性肝炎(NASH)和其他相关病症的用途。